Barclays Maintains Overweight on CSX, Raises Price Target to $47

Benzinga Newsdesk www.benzinga.com Positive 76.1%

Neg 0% Neu 0% Pos 76.1%

Barclays analyst Brandon Oglenski maintains CSX (NASDAQ:CSX) with a Overweight and raises the price target from $40 to $47.